EP 1305021 A1 20030502 - RAPIDLY EXPANDING COMPOSITION FOR GASTRIC RETENTION AND CONTROLLED RELEASE OF THERAPEUTIC AGENTS, AND DOSAGE FORMS INCLUDING THE COMPOSITION
Title (en)
RAPIDLY EXPANDING COMPOSITION FOR GASTRIC RETENTION AND CONTROLLED RELEASE OF THERAPEUTIC AGENTS, AND DOSAGE FORMS INCLUDING THE COMPOSITION
Title (de)
SCHNELL AUSDEHNENDE ZUSAMMENSETZUNG FÜR VERZÖGERUNG IM MAGEN UND KONTROLLIERTE FREISETZUNG VON WIRKSTOFFEN, UND DIESE ZUSAMMENSETZUNG ENTHALTENDE DARREICHUNGSFORMEN
Title (fr)
COMPOSITION A EXPANSION RAPIDE POUR RETENTION GASTRIQUE ET LIBERATION REGULEE D'AGENTS THERAPEUTIQUES, ET FORMES POSOLOGIQUES RENFERMANT CETTE COMPOSITION
Publication
Application
Priority
- US 0120134 W 20010622
- US 21383200 P 20000623
- US 21711000 P 20000710
- US 22321200 P 20000804
Abstract (en)
[origin: WO0200213A1] The present invention provides a pharmaceutical composition for use in a dosage form for oral administration to a patient. The composition expands upon contact with gastric fluid and promotes retention of the dosage form in the patient's stomach for a prolonged period of time. The present invention further provides pharmaceutical dosage forms containing an active ingredient, and the pharmaceutical composition. The forms are adapted for immediate or controlled release of the active ingredient. The dosage forms may be used advantageously in the treatment of Parkinson's disease with levodopa and hyperactivity and attention deficit disorder with methylphenidate.
IPC 1-7
IPC 8 full level
A61J 3/06 (2006.01); A61J 3/07 (2006.01); A61K 9/00 (2006.01); A61K 9/16 (2006.01); A61K 9/20 (2006.01); A61K 9/22 (2006.01); A61K 9/26 (2006.01); A61K 9/50 (2006.01); A61K 9/51 (2006.01); A61K 31/165 (2006.01); A61K 31/195 (2006.01); A61K 31/198 (2006.01); A61K 31/4458 (2006.01); A61K 31/663 (2006.01); A61K 47/02 (2006.01); A61K 47/26 (2006.01); A61K 47/32 (2006.01); A61K 47/36 (2006.01); A61K 47/38 (2006.01); A61P 25/00 (2006.01); A61P 25/16 (2006.01); A61P 25/28 (2006.01); A61P 43/00 (2006.01); C07D 211/34 (2006.01)
CPC (source: EP KR)
A61K 9/0065 (2013.01 - EP); A61K 31/663 (2013.01 - EP); A61P 25/00 (2017.12 - EP); A61P 25/16 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 43/00 (2017.12 - EP); B82B 3/00 (2013.01 - KR); G01N 33/50 (2013.01 - KR); B82Y 15/00 (2013.01 - KR)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0200213 A1 20020103; AU 2001268722 B2 20050811; AU 2001268722 B8 20050929; AU 6872201 A 20020108; CA 2412490 A1 20020103; CZ 2003199 A3 20031217; EA 200300046 A1 20031030; EP 1305021 A1 20030502; EP 1305021 A4 20090923; HU P0301465 A2 20040528; HU P0301465 A3 20060728; IL 153497 A0 20030706; JP 2004501190 A 20040115; KR 20030013460 A 20030214; MX PA02012793 A 20040730
DOCDB simple family (application)
US 0120134 W 20010622; AU 2001268722 A 20010622; AU 6872201 A 20010622; CA 2412490 A 20010622; CZ 2003199 A 20010622; EA 200300046 A 20010622; EP 01946709 A 20010622; HU P0301465 A 20010622; IL 15349701 A 20010622; JP 2002504995 A 20010622; KR 20027017538 A 20021223; MX PA02012793 A 20010622